Procaine

Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Procaine.png
Procaine
Systematic (IUPAC) name
2-(diethylamino)ethyl 4-aminobenzoate
Identifiers
CAS number 59-46-1
ATC code N01BA02 C05AD05 S01HA05
PubChem 4914
DrugBank APRD00650
Chemical data
Formula C13H20N2O2 
Mol. mass 236.31 g/mol
Pharmacokinetic data
Bioavailability n/a
Metabolism Hydrolysis by plasma esterases
Half life 40–84 seconds
Excretion Renal
Therapeutic considerations
Pregnancy cat.

B2(AU) C(US)

Legal status

Prescription Only (S4)(AU)

Routes Parenteral

WikiDoc Resources for

Procaine

Articles

Most recent articles on Procaine

Most cited articles on Procaine

Review articles on Procaine

Articles on Procaine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Procaine

Images of Procaine

Photos of Procaine

Podcasts & MP3s on Procaine

Videos on Procaine

Evidence Based Medicine

Cochrane Collaboration on Procaine

Bandolier on Procaine

TRIP on Procaine

Clinical Trials

Ongoing Trials on Procaine at Clinical Trials.gov

Trial results on Procaine

Clinical Trials on Procaine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Procaine

NICE Guidance on Procaine

NHS PRODIGY Guidance

FDA on Procaine

CDC on Procaine

Books

Books on Procaine

News

Procaine in the news

Be alerted to news on Procaine

News trends on Procaine

Commentary

Blogs on Procaine

Definitions

Definitions of Procaine

Patient Resources / Community

Patient resources on Procaine

Discussion groups on Procaine

Patient Handouts on Procaine

Directions to Hospitals Treating Procaine

Risk calculators and risk factors for Procaine

Healthcare Provider Resources

Symptoms of Procaine

Causes & Risk Factors for Procaine

Diagnostic studies for Procaine

Treatment of Procaine

Continuing Medical Education (CME)

CME Programs on Procaine

International

Procaine en Espanol

Procaine en Francais

Business

Procaine in the Marketplace

Patents on Procaine

Experimental / Informatics

List of terms related to Procaine

Procaine is a local anesthetic drug of the amino ester group. It is used primarily to reduce the pain of intramuscular injection of penicillin, and is also used in dentistry. Owing to the ubiquity of the trade name Novocain, procaine is sometimes referred to generically as novocaine or novacaine.

Procaine was first synthesized in 1905, and was the first injectable man-made local anesthetic used. It was created by the German chemist Alfred Einhorn (1857–1917) who gave the chemical the trade name Novocaine, from the Latin Novus (meaning New) and caine, a common ending for alkaloids used as anesthetics. It was introduced into medical use by surgeon Heinrich Braun (1862–1934).

Procaine is used less frequently today since more effective (and hypoallergenic) alternatives such as lidocaine (xylocaine) exist. Prior to the discovery of procaine, cocaine was the most commonly used local anesthetic. Procaine (like cocaine) has the advantage of constricting blood vessels, which reduces bleeding, unlike other local anesthetics like lidocaine, and without the euphoric and addictive qualities of cocaine.

Procaine, an ester anesthetic, is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-amino benzoic acid (PABA), which is then excreted by the kidneys into the urine. Allergic reactions to procaine are usually not in response to procaine itself, but to PABA. About 1 in 3000 people have an atypical form of pseudocholinesterase, which doesn't hydrolyze ester anesthetics such as procaine, resulting in a prolonged period of high levels of the anesthetic in the blood and increased toxicity.

Procaine is the primary ingredient in the controversial preparation Gerovital H3, which is claimed by its advocates to remedy many effects of aging. The mainstream medical view is that these claims were seriously studied and discredited in the 1960s.

See also

Cost Effectiveness of Procaine

| group5 = Clinical Trials Involving Procaine | list5 = Ongoing Trials on Procaine at Clinical Trials.govTrial results on ProcaineClinical Trials on Procaine at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Procaine | list6 = US National Guidelines Clearinghouse on ProcaineNICE Guidance on ProcaineNHS PRODIGY GuidanceFDA on ProcaineCDC on Procaine


| group7 = Textbook Information on Procaine | list7 = Books and Textbook Information on Procaine


| group8 = Pharmacology Resources on Procaine | list8 = AND (Dose)}} Dosing of ProcaineAND (drug interactions)}} Drug interactions with ProcaineAND (side effects)}} Side effects of ProcaineAND (Allergy)}} Allergic reactions to ProcaineAND (overdose)}} Overdose information on ProcaineAND (carcinogenicity)}} Carcinogenicity information on ProcaineAND (pregnancy)}} Procaine in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Procaine


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Procaine | list9 = AND (pharmacogenomics)}} Genetics of ProcaineAND (pharmacogenomics)}} Pharmacogenomics of ProcaineAND (proteomics)}} Proteomics of Procaine


| group10 = Newstories on Procaine | list10 = Procaine in the newsBe alerted to news on ProcaineNews trends on Procaine</small>


| group11 = Commentary on Procaine | list11 = Blogs on Procaine

| group12 = Patient Resources on Procaine | list12 = Patient resources on ProcaineDiscussion groups on ProcainePatient Handouts on ProcaineDirections to Hospitals Treating ProcaineRisk calculators and risk factors for Procaine


| group13 = Healthcare Provider Resources on Procaine | list13 = Symptoms of ProcaineCauses & Risk Factors for ProcaineDiagnostic studies for ProcaineTreatment of Procaine

| group14 = Continuing Medical Education (CME) Programs on Procaine | list14 = CME Programs on Procaine

| group15 = International Resources on Procaine | list15 = Procaine en EspanolProcaine en Francais

| group16 = Business Resources on Procaine | list16 = Procaine in the MarketplacePatents on Procaine

| group17 = Informatics Resources on Procaine | list17 = List of terms related to Procaine


}}

de:Procainit:Procaina

nl:Novocaïnesimple:Procaine sv:Prokain


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox
In other languages